|
|
Article: Acclarent, Inc. Granted Key Patent Covering Balloon Sinuplasty(TM) Technologies.
- Article from:
- Biotech Week
- Article date:
- May 20, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Acclarent, Inc., the pioneer of Balloon Sinuplasty(TM) technologies for use in the treatment of chronic sinusitis, announced that the U.S. Patent and Trademark Office awarded U.S. Patent Number 7,500,971, entitled "Devices, Systems and Methods for Treating Disorders of the Ear, Nose and Throat," to the company. This patent and Acclarent's earlier 7,462,175 patent are directed to methods for treating a paranasal sinus ostium, such as the maxillary sinus ostium, either through the nostril or other routes. The patented methods include advancing a balloon through a guide and using the balloon to dilate a paranasal sinus ostium. "In addition to securing protection for this ...
Related newspaper, magazine, and journal articles:
|
|
Article: American Rhinologic Society Releases Position Statement on ...
PR Newswire;
October 3, 2006 ;
700+ words
... ... A recently introduced technology for sinus disease, balloon sinuplasty, has limited surgical indications at this time, according ... others who may be interested in the technology. While balloon sinuplasty, which uses a balloon dilation technology similar to ...
|
|